학술논문
Equivalent immunogenicity across three RSVpreF vaccine lots in healthy adults 18–49 years of age: Results of a randomized phase 3 study
Document Type
Article
Author
Source
In: Vaccine . (Vaccine, 10 May 2024, 42(13):3172-3179)
Subject
Language
English
ISSN
18732518
0264410X
0264410X